Floatz logo

BOTULINUM B TOXIN

Traumatic Brain Injury

Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLCprotein_peptidePhase 2/3Active
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
39/ 100
Competitive Position
73/ 100

Competitive context

82 Active assets in the Traumatic Brain Injury cohort.

Asset / SponsorPhaseRating
MELATONIN
Children's National Research Institute
Phase 4BBB
Valproic Acid
Northwestern University
Phase 4BBB
Apsolol
Tanta University
Phase 4BBB
NEPENTHE
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase 4BB
Dexmedetomidine
Universitas Jenderal Soedirman
Phase 4BB

View all 50 →

Same molecule, other indications

BOTULINUM B TOXIN is also rated in:

stroke disorderActive
BB
Indicative · Phase 4
65 / 100
View asset →
neoplasmDormant
B
Indicative · Phase 4
61 / 100
View asset →
brain injuryDormant
B
Indicative · Phase 4
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →